FASEBnews |
January 23,
2002 |
Federation of
American Societies for Experimental Biology
Office of Public Affairs • 9650
Rockville Pike, Bethesda, Md. 20814-3998 • www.faseb.org
Contact: Paulette W.
Campbell
(301) 571-7795
mailto:campbell@opa.faseb.org
Bethesda, Md. — FASEB President Robert R. Rich,
M.D., praised the recently released National Academies' report, Scientific
and Medical Aspects of Human Reproductive Cloning. "On the basis of their thorough review
of the scientific evidence, the authors of this report have produced an
authoritative statement on human cloning," Dr Rich said. "Irving Weissman, the panel chair, and his colleagues should be
commended for an excellent job of reviewing the studies of animal cloning and
analyzing their implications for human beings."
The report
concludes that reproductive cloning poses significant dangers to the woman,
fetus and newborn, and as a result should be prohibited. Dr. Rich stated "FASEB has already endorsed
S. 1758, Sen. Dianne Feinstein's ‘Human Cloning Prohibition Act,' and we are
pleased that the Academy shares our view and calls for a statutory ban on the
cloning of human beings." Dr. Rich
urged the research community to support S. 1758 in the upcoming Senate debate
over human cloning.
In summarizing
the scientific and medical issues involved, the National Academies' report
clearly distinguishes human reproductive cloning – where the objective is to
create a child – from the use of somatic cell nuclear transfer techniques to
create stem cells. "By making a
clear and cogent distinction between these two activities, the National
Academies' report makes an excellent contribution to public education and
provides a sound basis for future policy discussions," Dr. Rich said. FASEB
supports the report's recommendation that stem cell research using somatic cell
nuclear transfer be permitted.
FASEB is comprised of 21 societies
with more than 60,000 members, making it the largest coalition of biomedical
research associations in the United
States. FASEB's mission is to enhance the ability of biomedical and
life scientists to improve — through their research— the health, well-being and
productivity of all people. FASEB serves the interests of these scientists in
those areas related to public policy; facilitates coalition activities among
Member Societies; and, disseminates information on
biological research through scientific conferences and publications.
###
Return to the FASEB
homepage
Return to the FASEB Office
of Public Affairs homepage